Indian Scientist develops human model to study brain disorders like autism
Team Udayavani, Aug 5, 2021, 11:20 AM IST
Source: unsplash
Yogita K. Adlakha, an Indian scientist has developed human-based models to study neuron development and neurodevelopmental disorders such as autism which can help design treatment strategies for such brain disorders
She is a recipient of INSPIRE Faculty fellowship instituted by the Department of Science and Technology (DST), has achieved this feat, the DST said on Wednesday. INSPIRE — which stands for Innovation in Science Pursuit for Inspired Research Programme — is a scheme by the DST for attracting talent towards science.
Since decades, animal models have been used to understand brain-related disorders, and the drugs which function in animal models have failed in clinical trials, therefore Adlakha filled this gap by generating a human-based stem cell model to understand brain development and dysfunction at the National Brain Research Centre, Manesar, Haryana.
At present, she works as a scientist at the Translational Health Science and Technology Institute, NCR Bio-cluster, Faridabad.
“The dearth of human models has led to a lack of knowledge of the pathophysiology of such disorders, an essential requirement for designing their treatment strategies,” the DST said.
Yogita filled this gap and developed a human-based model that could help study how the brain develops, particularly the neurons, and what goes awry during brain development leading to cognitive decline, impairment in language, and social interaction.
Along with her group, she derived induced pluripotent stem cells (iPSCs) from human peripheral blood and differentiated them into neural stem cells (NSCs).
Since levels of microRNA-137 are less in neuro-developmental disorders such as ASD and ID, her study demonstrates the crucial roles of this miRNA during human NSC fate determination with an elaboration of underlying molecular mechanisms. This study was published in the journal “STEM CELLS” recently.
“My research using DST INSPIRE fund has definitely contributed to expanding the knowledge of neuron development and neurodevelopmental disorders such as autism and the role of small non-coding miRNA in brain-specific stem cells fate,” Adlakha added.
Along with her research group, she established a protocol from India for the first time by generating and producing iPSCs from human peripheral blood. They have further refined the protocol of differentiation of iPSCs into brain-specific stem cells that are, NSCs.
Her group has contributed immensely towards understanding the role of microRNA in the neural stem cell fate, which revealed how certain small non-coding RNAs called microRNA, which does not form protein but regulate expression of other genes, can enhance the differentiation of neural stem cells into neurons.
Her research has contributed to expanding the knowledge of neuron development and the role of small non-coding miRNA in brain-specific stem cells fate, thereby changing the face of neuroscience and stem cells.
(Written with inputs from IANS.)
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
World Diabetes Day: An overview of types of diabetes
World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates
Disruption in liver-brain communication behind overeating, Study claims
Acute Blood Shortage at Kasturba Hospital, Manipal: Donate blood and save lives
MUST WATCH
Latest Additions
Congress’ guarantees implemented in Karnataka amid BJP’s false propaganda: Shivakumar
Followers of Sanatan Dharma will respond to those disrespecting it: Pawan Kalyan
Pushpa bows down to no one, but will do so for you: Allu Arjun to fans at ‘Pushpa 2’ trailer launch
Priyanka Gandhi leads roadshow in Nagpur
Sport teaches values beyond competition: Srihari Nataraj
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.